Vistagen today announced that PH80, one of the Company’s five investigational neuroactive nasal sprays, demonstrated statistically significant efficacy versus placebo in an exploratory Phase 2A study for the acute treatment of hot flashes (vasomotor symptoms) in women diagnosed with menopausal hot flashes.
Mozart Therapeutics today announced it has raised $25 million from new investors in a Series A extension, bringing the total raise to $80 million.
Magenta Medical , developer of the world’s smallest heart pump, announced today the initiation of its FDA-approved Early Feasibility Study with the Elevate™ percutaneous Left Ventricular Assist Device.
First Patients Treated in the US with the World’s Smallest Heart Pump Read More »
The Federal Trade Commission’s lawsuit takes an unusual strategy, according to legal experts, raising concerns and uncertainties in the biopharma industry.
FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention Read More »
Fusion Pharmaceuticals Inc. today announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 68,000 shares of its common stock to two employees outside Fusion’s 2020 Stock Option and Incentive Plan.
Lobe Sciences Ltd. today announced the appointment of Baxter Phillips III, MBA, to the newly created position of Chief Operating Officer (COO) effective immediately.
Lobe Sciences Appoints Baxter Phillips III, MBA as Chief Operating Officer Read More »
Prenosis Inc. , an artificial intelligence company enabling precision medicine in acute care, announced today it has been awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR), within the U.S. Department of Health and Human Services (HHS), a U.S. government agency.
Prenosis Inc. Receives BARDA Contract to Study Utility of Its Sepsis Diagnostic Tool Read More »
NanOlogy LLC, a clinical-stage oncology company, announces a presentation of clinical research involving its large surface area microparticle investigational drugs at DDW 2023 in May and publication at ASCO Annual Meeting in June.
Dizal presented compelling data of its robust oncology portfolio at the 2023 American Society of Clinical Oncology Annual Meeting taking place June 2-6, 2023, in Chicago.
Con el creciente interés en la energía solar y la adopción de sistemas fotovoltaicos en los hogares, surge la pregunta de si incorporar baterías en estos sistemas es una opción viable. Las baterías de almacenamiento de energía ofrecen la posibilidad d …
